Mark Yeoman

Dr, Ph.D Neuropharmacology, Director of the Centre for Stress and Age-related Disease

19952019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mark Yeoman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Medicine & Life Sciences

Lymnaea
Snails
FMRFamide
Giant Cells
Central Pattern Generators
Interneurons
Neuropeptides
Serotonin
Colon
Feeding Behavior
Neurons
Genes
Constipation
Acetylcholine
Cardiac Myocytes
Peptides
Invertebrates
Cholinergic Agents
Motor Neurons
Anal Canal
Sodium-Calcium Exchanger
Hydroxyindoleacetic Acid
Nitric Oxide
Nerve Fibers
Muscle Contraction
Interstitial Cells of Cajal
Cheek
Fecal Impaction
Action Potentials
Ganglia
Pharmacology
Cell Aging
Biomedical Technology Assessment
Nitric Oxide Synthase Type I
Citalopram
Paraquat
Inositol 1,4,5-Trisphosphate
Microelectrodes
Genotype
Sucrose
Second Messenger Systems
Propofol
Melatonin
Renin-Angiotensin System
Central Nervous System

Chemical Compounds

Serotonin
Dopamine
High performance liquid chromatography
Neurotransmitter Agents
Tissue
Electrodes
Electric potential
Kynurenine